US3278447A
(en)
*
|
1963-12-02 |
1966-10-11 |
Cloro Bac Products Inc |
Process for stabilizing chlorine dioxide solution
|
FI65914C
(en)
*
|
1978-03-07 |
1984-08-10 |
Sandoz Ag |
FRAMEWORK FOR PHARMACEUTICAL COMPOSITION OF CYCLOSPORINE A
|
FR2561919B1
(en)
*
|
1984-04-03 |
1986-12-19 |
Roussel Uclaf |
PHARMACEUTICAL COMPOSITION CONSTITUTED ON THE ONE HAND, AS ACTIVE INGREDIENT, BY 9A, 11B-DICHLORO 16A-METHYL 21-OXYCARBONYLDICYCLOHEXYL METHYLOXY PREGNA-1,4-DIENE 3,20-DIONE AND ON THE OTHER HAND, BY A PHARM EXCIPIENT INERTE CAPABLE OF ALLOWING THE ACTION OF THE PRODUCT IN THE RECTUM OR THE COLON
|
US5639724A
(en)
*
|
1984-07-24 |
1997-06-17 |
Sandoz Ltd. |
Cyclosporin galenic forms
|
US4649047A
(en)
*
|
1985-03-19 |
1987-03-10 |
University Of Georgia Research Foundation, Inc. |
Ophthalmic treatment by topical administration of cyclosporin
|
US4814323A
(en)
*
|
1986-03-25 |
1989-03-21 |
Andrieu J M |
Process for the treatment and the prevention of AIDS and other disorders induced by the LAV/HTLV III virus
|
KR920003601B1
(en)
*
|
1987-09-03 |
1992-05-04 |
유니버시티 어브 죠지아 리서취 화운데이션 인코포레이티드 |
Ocular cyclosporin composition
|
US4839342A
(en)
*
|
1987-09-03 |
1989-06-13 |
University Of Georgia Research Foundation, Inc. |
Method of increasing tear production by topical administration of cyclosporin
|
US5236899A
(en)
*
|
1987-11-16 |
1993-08-17 |
Merck & Co., Inc. |
6-position cyclosporin a analogs as modifiers of cytotoxic drug resistance
|
GB8729153D0
(en)
*
|
1987-12-14 |
1988-01-27 |
Efamol Ltd |
Fatty acid compositions
|
ES2033086T3
(en)
*
|
1988-01-29 |
1993-03-01 |
Sankyo Company Limited |
A PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION.
|
CH679119A5
(en)
*
|
1988-05-13 |
1991-12-31 |
Sandoz Ag |
|
US5342625A
(en)
*
|
1988-09-16 |
1994-08-30 |
Sandoz Ltd. |
Pharmaceutical compositions comprising cyclosporins
|
KR0148748B1
(en)
*
|
1988-09-16 |
1998-08-17 |
장 크라메르, 한스 루돌프 하우스 |
A multiphase cyclosporin composition
|
US5540931A
(en)
*
|
1989-03-03 |
1996-07-30 |
Charles W. Hewitt |
Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants
|
US4996193A
(en)
*
|
1989-03-03 |
1991-02-26 |
The Regents Of The University Of California |
Combined topical and systemic method of administration of cyclosporine
|
US5294604A
(en)
*
|
1989-12-20 |
1994-03-15 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Method of treating ocular diseases by periocular administration of cyclosporine A or G
|
FI111730B
(en)
*
|
1990-11-02 |
2003-09-15 |
Novartis Ag |
A process for the preparation of a non-immunosuppressive cyclosporin
|
GB9105705D0
(en)
*
|
1991-03-18 |
1991-05-01 |
Sandoz Ltd |
Improvements in or relating to organic compounds
|
IL102236A0
(en)
*
|
1991-06-27 |
1993-01-14 |
Ltt Inst Co Ltd |
Topical preparations containing cyclosporin
|
US5286731A
(en)
*
|
1991-09-17 |
1994-02-15 |
American Home Products Corporation |
Method of treating immunoinflammatory bowel disease
|
US5286730A
(en)
*
|
1991-09-17 |
1994-02-15 |
American Home Products Corporation |
Method of treating immunoinflammatory disease
|
EP0642332B1
(en)
*
|
1992-05-13 |
1997-01-15 |
Sandoz Ltd. |
Ophthalmic compositions containing a cyclosporin
|
US5368854A
(en)
*
|
1992-08-20 |
1994-11-29 |
Schering Corporation |
Use of IL-10 to treat inflammatory bowel disease
|
ES2168271T3
(en)
*
|
1992-09-25 |
2002-06-16 |
Novartis Ag |
PHARMACEUTICAL COMPOSITIONS CONTAINING CYCLOSPORINS.
|
US5843452A
(en)
*
|
1992-11-09 |
1998-12-01 |
Pharmagenesis, Inc. |
Immunotherapy composition and method
|
NZ247516A
(en)
*
|
1993-04-28 |
1995-02-24 |
Bernard Charles Sherman |
Water dispersible pharmaceutical compositions comprising drug dissolved in solvent system comprising at least one alcohol and at least one surfactant
|
US6323204B1
(en)
*
|
1993-10-13 |
2001-11-27 |
Allergan |
Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives
|
US6022852A
(en)
*
|
1993-10-22 |
2000-02-08 |
Hexal Ag |
Pharmaceutical composition containing cyclosporin A
|
US5891846A
(en)
*
|
1994-02-17 |
1999-04-06 |
Shiseido Company, Ltd. |
Cyclosporin-containing emulsion composition
|
US5474979A
(en)
*
|
1994-05-17 |
1995-12-12 |
Allergan, Inc. |
Nonirritating emulsions for sensitive tissue
|
WO1995032726A1
(en)
*
|
1994-06-01 |
1995-12-07 |
Yuhan Corporation |
Cyclosporin containing composition and process for the preparation thereof
|
JP3833248B2
(en)
*
|
1994-11-03 |
2006-10-11 |
ノバルティス・アクチエンゲゼルシャフト |
Novel formulation of cyclosporine for oral administration with simple composition and high bioavailability and process for its production
|
US6696413B2
(en)
*
|
1995-06-16 |
2004-02-24 |
Hexal Ag |
Pharmaceutical preparation with cyclosporin A
|
EP0760237A1
(en)
*
|
1995-08-30 |
1997-03-05 |
Cipla Limited |
Oil-in-water microemulsions
|
NZ280689A
(en)
*
|
1995-12-15 |
1997-08-22 |
Bernard Charles Sherma Sherman |
Pharmaceutical composition comprising a cyclosporipharmaceutical composition comprising a cyclosporin; a tocol, tocopherol or tocotrienol; and propylen; a tocol, tocopherol or tocotrienol; and propylene carbonate or polyethylene glycol ne carbonate or polyethylene glycol
|
CZ288631B6
(en)
*
|
1996-01-18 |
2001-08-15 |
Galena, A. S. |
Therapeutic preparations containing cyclosporin
|
US5858401A
(en)
*
|
1996-01-22 |
1999-01-12 |
Sidmak Laboratories, Inc. |
Pharmaceutical composition for cyclosporines
|
US5958876A
(en)
*
|
1996-06-19 |
1999-09-28 |
Novartis Ag |
Cyclosporin-containing pharmaceutical compositions
|
US20020025925A1
(en)
*
|
1996-09-20 |
2002-02-28 |
Wood Lars Michael |
Combination therapy
|
ES2236891T3
(en)
*
|
1997-03-12 |
2005-07-16 |
Abbott Laboratories |
HYDROFILE BINARY SYSTEMS FOR THE ADMINISTRATION OF CYCLOSPORINE.
|
NZ314702A
(en)
*
|
1997-04-29 |
1998-07-28 |
Bernard Charles Sherman |
Pharmaceutical composition comprising a cyclosporin in a solvent system of acetylated monoglycerides and a surfactant and optionally a hydrophilic solvent
|
US6346511B1
(en)
*
|
1997-09-08 |
2002-02-12 |
Panacea Biotec Limited |
Pharmaceutical composition comprising cyclosporin
|
US6008191A
(en)
*
|
1997-09-08 |
1999-12-28 |
Panacea Biotec Limited |
Pharmaceutical compositions containing cyclosporin
|
JP4761093B2
(en)
*
|
1997-12-10 |
2011-08-31 |
シクロスポリン セラポイティクス リミテッド |
Pharmaceutical composition comprising omega-3 fatty acid oil
|
US5981607A
(en)
*
|
1998-01-20 |
1999-11-09 |
Allergan |
Emulsion eye drop for alleviation of dry eye related symptoms in dry eye patients and/or contact lens wearers
|
TW581681B
(en)
*
|
1998-02-20 |
2004-04-01 |
Nektar Therapeutics |
Liquid crystal forms of cyclosporin
|
DE19810655A1
(en)
|
1998-03-12 |
1999-09-16 |
Univ Eberhard Karls |
Pharmaceutical composition containing cyclosporin A suitable for topical administration for treating disorders of skin, mucosa and eyes
|
CA2332699A1
(en)
*
|
1998-07-07 |
2000-01-13 |
Hisamitsu Pharmaceutical Co., Inc. |
Antisense oligonucleotides targeted to il-15
|
US6254860B1
(en)
*
|
1999-04-13 |
2001-07-03 |
Allergan Sales, Inc. |
Ocular treatment using cyclosporin-A derivatives
|
DE60100866T2
(en)
*
|
2000-04-07 |
2004-07-29 |
Laboratoire Medidom S.A. |
Ophthalmic medicinal product containing cyclosporine, hyaluronic acid and polysorbate
|
US6784156B2
(en)
*
|
2001-03-05 |
2004-08-31 |
Enanta Pharmaceuticals, Inc. |
Cyclosporins for the treatment of respiratory diseases
|
US6713081B2
(en)
*
|
2001-03-15 |
2004-03-30 |
The United States Of America As Represented By The Department Of Health And Human Services |
Ocular therapeutic agent delivery devices and methods for making and using such devices
|
WO2002074316A1
(en)
*
|
2001-03-15 |
2002-09-26 |
Enteron Pharmaceuticals, Inc. |
Method of treating inflammatory disorders of the gastrointestinal tract using topical active corticosteroids
|
CA2449671A1
(en)
*
|
2001-06-06 |
2002-12-12 |
The Regents Of The University Of Michigan |
Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enyzmes
|
CA2452372A1
(en)
*
|
2001-07-06 |
2003-01-16 |
Sucampo Ag |
Composition for topical administration comprising an interleukin-2 inhibitor and an antimicrobial agent
|
US6872705B2
(en)
*
|
2001-07-13 |
2005-03-29 |
Allergan, Inc. |
Use of antimicrobial peptides as preservatives in ophthalmic preparations, including solutions, emulsions, and suspensions
|
US20030087813A1
(en)
*
|
2001-10-12 |
2003-05-08 |
Or Yat Sun |
Cyclosporin analogs for the treatment of lung diseases
|
US6809077B2
(en)
*
|
2001-10-12 |
2004-10-26 |
Enanta Pharmaceuticals, Inc. |
Cyclosporin analogs for the treatment of autoimmune diseases
|
AU2003301347A1
(en)
*
|
2002-10-17 |
2004-05-04 |
Control Delivery Systems, Inc. |
Methods for monitoring treatment of disease
|